The article cites the authors’ analysis of hospital data, which shows unexpectedly high rates of antibiotic resistance in several bacteria, including:
- A. baumanii to carbapenems, greater than 50 percent (CDC: 11 percent), rendering carbapenems obsolete for treatment.
- E. coli to third generation cephalosporins, between 8 and 11 percent (CDC: 5 percent)
- K. pneumonia to third generation cephalosporins, between 20 and 27 percent (CDC: 15 percent)
The article also determines that the Food and Drug Administration’s pledge to renew efforts in antibiotic development has fallen short of its goals.
The authors call for “a complete overhaul” of approaches to antibiotic resistance, disease and prevention, according to a digest of the article by ScienceDaily.
More Articles on Quality:
7 Biggest Safety Challenges in the OR
U.S. News Responds to Criticism of Best Hospital List
Sharps Safety Law Effectively Decreased Injury 33%, Study Says
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
